Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NephroGenex, Inc. | 659,430 | reported | 10 Nov 2015 | tx 7+998,193 |
| RITE AID CORP | 206,505 | reported | 26 Jun 2008 | tx 7+715,836−16,662 |
| Syndax Pharmaceuticals Inc | 114,000 | reported | 04 Feb 2026 | tx 34+328,000−214,000 |
| BICYCLE THERAPEUTICS PLC | 46,000 | reported | 02 Jan 2025 | tx 38+636,654−390,000 |
| XCYTE THERAPIES INC | 35,000 | reported | 19 Feb 2008 | tx 2+70,000 |
| Regado Biosciences Inc | 0 | reported | 01 Nov 2016 | tx 9+197,359−57,619 |
| ARMO BioSciences, Inc. | 0 | reported | 22 Jun 2018 | tx 3+18,000−73,765 |
| FOREST LABORATORIES INC | 0 | reported | 01 Jul 2014 | tx 7+27,670−27,670 |
| OSI PHARMACEUTICALS INC | 0 | reported | 03 Jun 2010 | tx 9+181,500−181,500 |
| Urovant Sciences Ltd. | 0 | reported | 29 Mar 2021 | tx 11+98,130−111,480 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 24,000 | 0.00 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 25,000 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | BICYCLE THERAPEUTICS PLC | 12,500 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | BICYCLE THERAPEUTICS PLC | 25,000 | 0.00 USD | deriv |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 17,000 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | BICYCLE THERAPEUTICS PLC | 12,000 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | BICYCLE THERAPEUTICS PLC | 24,000 | 0.00 USD | deriv |
| 02 Feb 2023 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 16,000 | 0.00 USD | |
| 13 Jan 2023 | SALE | Syndax Pharmaceuticals Inc | 5,000 | 27.00 USD | |
| 12 Jan 2023 | SALE | Syndax Pharmaceuticals Inc | 24,000 | 26.74 USD | |
| 12 Jan 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 24,000 | 9.47 USD | |
| 13 Jan 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 10,000 | 13.58 USD | |
| 13 Jan 2023 | SALE | Syndax Pharmaceuticals Inc | 10,000 | 27.00 USD | |
| 13 Jan 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 5,000 | 13.58 USD | |
| 13 Jan 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 10,000 | 0.00 USD | deriv |
| 13 Jan 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 5,000 | 0.00 USD | deriv |
| 12 Jan 2023 | EXERCISE | Syndax Pharmaceuticals Inc | 24,000 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | BICYCLE THERAPEUTICS PLC | 11,500 | 0.00 USD | |
| 03 Jan 2023 | GRANT_AWARD | BICYCLE THERAPEUTICS PLC | 23,000 | 0.00 USD | deriv |
| 05 Aug 2022 | EXERCISE | Syndax Pharmaceuticals Inc | 10,000 | 9.63 USD | |
| 05 Aug 2022 | SALE | Syndax Pharmaceuticals Inc | 10,000 | 23.02 USD | |
| 05 Aug 2022 | EXERCISE | Syndax Pharmaceuticals Inc | 14,000 | 8.93 USD | |
| 05 Aug 2022 | SALE | Syndax Pharmaceuticals Inc | 14,000 | 23.02 USD | |
| 05 Aug 2022 | EXERCISE | Syndax Pharmaceuticals Inc | 10,000 | 0.00 USD | deriv |
| 05 Aug 2022 | EXERCISE | Syndax Pharmaceuticals Inc | 14,000 | 0.00 USD | deriv |